[1]
2024. Potent antitumor activity of a bispecific T-cell engager antibody targeting the intracellular antigen KRAS G12V. Biomolecules and Biomedicine. 24, 5 (Sep. 2024), 1424–1434. DOI:https://doi.org/10.17305/bb.2024.10431.